Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting

clinical trial

Wikidata entity: Q65386166



Quantities

P2899minimum age18
P1132number of participants400

P6099 clinical trial phase ... Q42824440 (phase II clinical trial) phase II clinical trial
P6099 clinical trial phase ... Q42824827 (phase III clinical trial) phase III clinical trial
P17 country ... Q30 (United States) United States
P17 country ... Q183 (Germany) Germany
P31 instance of ... Q30612 (clinical trial) clinical trial
P6153 research site ... Q501758 (University of Florida) University of Florida
P6153 research site ... Q4117596 (Cleveland Clinic) Cleveland Clinic
P6153 research site ... Q4897536 (Beth Israel Deaconess Medical Center) Beth Israel Deaconess Medical Center
P6153 research site ... Q6523170 (Lenox Hill Hospital) Lenox Hill Hospital
P6153 research site ... Q7191520 (Piedmont Hospital) Piedmont Hospital
P6153 research site ... Q30280293 (Jewish Hospital) Jewish Hospital
P580 start time ... 2006-11-01 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext Protection During Carotid Stenting in High Risk Patients With the TriActiv ProGuard System ???

External Ids
P3098ClinicalTrials.gov IDNCT00395785

Why not click here or view trends?

log id: 4706543